ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

Letter: Medicare Policy May Delay Access to Cancer Drugs

June 13, 2003

FDA Names Director Of New Center For Tobacco Products

September 11, 2009

AACI Asks Funding Of Cancer Control Directors From Control Budget

February 11, 1983

In Brief: Susan Braun Named CEO, Komen Foundation; NCCF Research Fellowship Honors Norman

July 12, 1996

In Brief: Moffitt Cancer Center Awarded Core Grant; Biotech Industry Honors Jeffords, Bliley

May 29, 1998